Nailesh Bhatt has more than twenty-five years of experience in the pharmaceutical industry with a wide range of companies including start-ups, Fortune 500, private equity owned, and publicly traded companies. A serial entrepreneur, Nailesh is Founder and CEO of VGYAAN Pharmaceuticals. He is also Founder and Managing Director of Proximare, a strategic advisory firm with presence in the US and India. Prior to Proximare, Nailesh was the founder of BulkDrugs.com. Previously, Nailesh has worked in increasing roles and responsibilities at Sidmak Laboratories, SEPPIC and Arthur Andersen.
Nailesh brings a wealth of knowledge and relationships to QHP Capital for a wide range of strategic issues, including: 505(B)(2), generics, CROs, CMOs, wholesalers, distributors, PBMs, payers, retailers, GPOs, specialty pharmacy, and more.
Nailesh currently serves as a member of Board of Directors of five companies including three QHP Capital portfolio companies: Azurity Pharmaceuticals, CoreRx Pharma, and Spectra Medical Devices. In addition, Nailesh is a member of Board of Directors of Sonnet BioTherapeutics (NASDAQ: SONN), and VGYAAN Pharmaceuticals.